Our Companoid Labs

It's symbolic news, but it's not that good news, so I don't think I can talk about it. It's a life semantics story.

Our Companoid Labs holding company is busy and investments in digital healthcare are mainly looked at through DHP, so I don't think I've posted much about healthcare recently.

However, I'm constantly interested in it, but I'm going to talk about it when the DHP Academy opens this year, but it's not on the instructor list, so I'm going to talk about it through another place soon.

In fact, in the context of consistent user health care in digital healthcare for years, he has been preaching in terms of sensor-based data collection, algorithms that convert it into valid information, and UX design that applies it to the user's behavioral intervention. However, few startups have done this properly.

The reason is that all three require a high degree of technology and creativity. It is not easy for a company to do well. Doctor Diary, which I am still a shareholder and advisor with since my initial investment, has been well-invested, and I have made a bet on the Pre IPO because one or two of those three have been done with several service levels. On the surface, commerce and brands stand out and are directly connected to sales, but this also acts as an important mechanism for inducing action.

Anyway, I changed this idea last year, which I've been preaching for years. This is because there is virtually no digital healthcare company for Donber due to user intervention. Regardless of the startup conglomerates, there is no such thing. The reason why the DTx sector is gloomy is that there is an inherent limitation in that lazy humans consider taking pills better because they clinically prove the effect of user intervention, obtain medical device approval, and use it as a compulsory means. Literally, user journey modeling cannot beat human nature.

Anyway, in this respect, whether or not Life Symantics is competent or controversial, it is one of the few digital healthcare companies in the digital healthcare sector and one of the startups that has almost finished the national task over the past few years, whose end of the life cycle has been passed too quickly, futilely, and even to a company whose assets have nothing to do with digital healthcare.

I think it will be difficult for many of the numerous digital healthcare companies established between 2017 and 2021 to even go on the path of Life Symantics. The overall economic market is also bad, but the digital healthcare sector has been struggling because it has not made a lot of money, so it seems difficult for the absolute amount and quality of soil for good founders to come out for a while.

It's not an easy field, but it's a pity that the talk is not going well on the last way (?) to go. Numerous digital healthcare start-ups have become good at distinguishing between good and bad, so I hope there will be a number of start-ups that can give hope in this case. Of course, I hope that among the many companies I have invested in, such companies will come out.